- United Kingdom
Henry Stemplewski is an Expert Non-clinical Assessor in the Medicines and Healthcare products Regulatory Agency (MHRA), the competent regulatory authority for human medicines, located in London. He also is an assessor for the environmental risk assessment.
He has worked in the Licensing Division of the MHRA for over 20 years. He has extensive experience in the assessment of human medicinal products including new chemical entities, biological medicines and clinical trials.
He has previously worked the UK’s Ministry of Agriculture, Fisheries and Food (MAFF, now renamed as the Department for Environment, Food and Rural Affairs) as a toxicologist. This involved the assessment of the toxicity of agrochemicals.
Before joining MAFF, he started his working career by research into oxygen monitoring probes for premature neonates at University College Hospital, London. Subsequently he conducted research into cell turn over rates in the gastrointestinal tract in disease states at the Royal Postgraduate Medical School (now renamed Imperial College) at Hammersmith Hospital, London. He then worked as a research toxicologist in a laboratory based at St. Bartholomew’s Hospital in London.
He was, until its disestablishment, a member of the CHMP SWP ad-hoc expert working group on environmental risk assessment which produced the technical Guideline published by the European Medicines Agency in June 2006.
He has been a member of the British Toxicology Society since 1984, and is currently the Chair of the Regulatory Toxicology Speciality Section. He has been appointed as a Fellow of the BTS. He is also a member of the British Society for Nanomedicines.